- Home
- ARWR vs HRMY Comparison
ARWR vs HRMY Comparison
Compare ARWR & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- HRMY
- Stock Information
- Founded
- ARWR 2003
- HRMY 2017
- Country
- ARWR United States
- HRMY United States
- Employees
- ARWR N/A
- HRMY N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- ARWR Health Care
- HRMY Health Care
- Exchange
- ARWR Nasdaq
- HRMY Nasdaq
- Market Cap
- ARWR 1.7B
- HRMY N/A
- IPO Year
- ARWR 1993
- HRMY 2020
- Fundamental
- Price
- ARWR $12.74
- HRMY $33.19
- Analyst Decision
- ARWR Buy
- HRMY Strong Buy
- Analyst Count
- ARWR 11
- HRMY 8
- Target Price
- ARWR $41.44
- HRMY $54.00
- AVG Volume (30 Days)
- ARWR 1.6M
- HRMY 669.0K
- Earning Date
- ARWR 05-08-2025
- HRMY 04-29-2025
- Dividend Yield
- ARWR N/A
- HRMY N/A
- EPS Growth
- ARWR N/A
- HRMY 17.84
- EPS
- ARWR N/A
- HRMY 2.51
- Revenue
- ARWR $2,500,000.00
- HRMY $714,734,000.00
- Revenue This Year
- ARWR $4,380.43
- HRMY $20.92
- Revenue Next Year
- ARWR $58.72
- HRMY $18.83
- P/E Ratio
- ARWR N/A
- HRMY $13.22
- Revenue Growth
- ARWR N/A
- HRMY 22.80
- 52 Week Low
- ARWR $12.20
- HRMY $28.14
- 52 Week High
- ARWR $30.41
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- ARWR 27.27
- HRMY 43.39
- Support Level
- ARWR $14.69
- HRMY $32.85
- Resistance Level
- ARWR $15.65
- HRMY $33.77
- Average True Range (ATR)
- ARWR 0.78
- HRMY 1.22
- MACD
- ARWR -0.12
- HRMY 0.02
- Stochastic Oscillator
- ARWR 13.07
- HRMY 28.66
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.